The scheme seeks to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies.
The scheme aims at providing long term capital appreciation and generating income with a diversified portfolio of Mid Cap companies.
9.0% of the combined portfolio weight is common between Mahindra Manulife Mid Cap Fund Direct-Growth and Quant Mid Cap Fund Direct-Growth.
6 stocks appear in both portfolios.
The largest shared holding is Nippon Life India Asset Management Ltd., at 2.67% of Mahindra Manulife Mid Cap Fund Direct-Growth and 4.52% of Quant Mid Cap Fund Direct-Growth.
The two funds hold largely different portfolios, so holding both can genuinely diversify your equity exposure.
Largest common holdings
Nippon Life India Asset Management Ltd.Indus Towers Ltd.Anthem Biosciences Ltd.JSW Infrastructure Ltd.LG Electronics India Ltd.Godrej Properties Ltd.
Mahindra Manulife Mid Cap Fund Direct-Growth has delivered the higher 3-year CAGR (22.61% vs 14.83%). Mahindra Manulife Mid Cap Fund Direct-Growth is the cheaper of the two with an expense ratio of 0.75% against 1.18%. Quant Mid Cap Fund Direct-Growth manages the larger corpus at ₹8.14k Cr. There is no single "better" fund — the right choice depends on your holding period, risk appetite and what you already own. Use the returns, risk and portfolio overlap tables above to judge which fits your portfolio, and remember that past returns do not guarantee future performance.
Over 1 year, Mahindra Manulife Mid Cap Fund Direct-Growth returned 15.49% against 6.94% for Quant Mid Cap Fund Direct-Growth; and over 3 years, Mahindra Manulife Mid Cap Fund Direct-Growth leads with a 22.61% CAGR versus 14.83%. Returns beyond one year are CAGR (annualised). Short-period returns are heavily influenced by market cycles, so compare over at least three to five years before drawing conclusions.
Mahindra Manulife Mid Cap Fund Direct-Growth has the lower expense ratio at 0.75%, compared with 1.18% for Quant Mid Cap Fund Direct-Growth — a difference of 0.43% a year. The expense ratio is deducted from NAV daily, so a lower ratio directly improves your net return, though it should not be the only reason to pick a fund.
Both Mahindra Manulife Mid Cap Fund Direct-Growth and Quant Mid Cap Fund Direct-Growth carry a "Very High" rating on the SEBI Riskometer. Within the same riskometer band, differences still show up in maximum drawdown, volatility and market-cap mix — all of which are compared in the tables above.
The portfolio overlap between the two funds is 9.0%, which is considered low. At this level the two funds hold largely different portfolios, so holding both can genuinely diversify your equity exposure. You can see the shared stocks in the overlap section above.
Yes — both are Equity: Mid Cap funds, which means they follow similar mandates and are benchmarked against comparable indices. That makes a direct comparison of returns, expense ratio and risk meaningful.
Mahindra Manulife Mid Cap Fund Direct-Growth has a NAV of ₹42.46 and an AUM of ₹5.08k Cr, and was launched on 29 Jan 2018. Quant Mid Cap Fund Direct-Growth has a NAV of ₹254.50 and an AUM of ₹8.14k Cr, launched on 31 Dec 2012. NAV on its own says nothing about how expensive or cheap a fund is — only the return on it matters.
